McKeough Jen E, Sharpley Christopher F, Vessey Kirstan A, Bitsika Vicki, Williams Rebecca J, Odierna G Lorenzo, Evans Ian D
Brain-Behaviour Research Group, University of New England, Armidale, NSW 2351, Australia.
Brain Sci. 2025 May 19;15(5):525. doi: 10.3390/brainsci15050525.
BACKGROUND/OBJECTIVES: Major Depressive Disorder (MDD) is a neuropsychiatric disorder affecting nearly 200 million people worldwide. While it has broad health effects, relatively little is known about how these vary across MDD 'subtypes', which reflect distinct symptom profiles. This systematic review examined the methods used to define several MDD subtypes and their associations with physical, cognitive, social, and functional health outcomes.
A systematic search of PubMed was conducted in accordance with PRISMA 2020 guidelines to identify peer-reviewed studies published in English between 2014 and 2025. The final search was conducted on 21 January 2025. Studies were included if they examined adults with MDD subtypes and reported health-related outcomes. Risk of bias was assessed using the Newcastle-Ottawa Scale. A narrative synthesis was conducted due to heterogeneity in the subtype definitions and outcome measures.
Sixteen studies were included. Atypical and melancholic depression were most consistently associated with metabolic dysfunction, higher BMI, and a greater waist circumference. Melancholic depression was frequently associated with cognitive deficits, though results varied. Cognitive impairments were also observed in DSM-defined atypical depression, particularly in attention, vigilance, and social cognition. Anxious and melancholic depression may be associated with more severe social and functional impairment compared to other subtypes. However, the findings were limited by inconsistent definitions and outcome measures.
Some subtypes, particularly atypical, melancholic, and anxious depression, are differentially associated with specific patterns of impairment, though inconsistencies limit firm conclusions.
This review was retrospectively registered with the Open Science Framework (OSF): No specific funding was received.
背景/目的:重度抑郁症(MDD)是一种神经精神疾病,全球有近2亿人受其影响。虽然它对健康有广泛影响,但对于这些影响如何因MDD“亚型”而异却知之甚少,这些亚型反映了不同的症状特征。本系统评价研究了用于定义几种MDD亚型的方法及其与身体、认知、社会和功能健康结局的关联。
根据PRISMA 2020指南对PubMed进行系统检索,以确定2014年至2025年间以英文发表的同行评审研究。最终检索于2025年1月21日进行。纳入的研究需涉及患有MDD亚型的成年人并报告与健康相关的结局。使用纽卡斯尔-渥太华量表评估偏倚风险。由于亚型定义和结局测量存在异质性,因此进行了叙述性综合分析。
纳入了16项研究。非典型抑郁症和抑郁性抑郁症最常与代谢功能障碍、较高的体重指数和更大的腰围相关。抑郁性抑郁症常与认知缺陷相关,不过结果存在差异。在DSM定义的非典型抑郁症中也观察到认知障碍,尤其是在注意力、警觉性和社会认知方面。与其他亚型相比,焦虑性抑郁症和抑郁性抑郁症可能与更严重的社会和功能损害相关。然而,这些发现受到定义和结局测量不一致的限制。
一些亚型,特别是非典型、抑郁性和焦虑性抑郁症,与特定的损害模式存在差异关联,尽管不一致性限制了得出确切结论。
本评价在开放科学框架(OSF)上进行了回顾性注册:未获得特定资金。